# Alcami Carolinas Corporation - Inspection Records

Source: https://www.keypedia.com/companies/alcami-carolinas-corporation/c58574ae-b205-4ac2-ae4c-ef29281b0110

> Inspection records and compliance data for Alcami Carolinas Corporation in Wilmington, North Carolina. Access full analysis and detailed observations.

---

## Details

- Name: Alcami Carolinas Corporation
- FEI Number: 1049418
- City: Wilmington
- State: North Carolina
- Country Name: United States
- Address Line 1: 2320 Scientific Park Dr
- Zip Code: 28405
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK, REPACK

## Related Documents

- [EIR - Alcami Carolinas Corporation - 2025-09-26](https://www.keypedia.com/records/eir/alcami-carolinas-corporation/9a497985-be75-4224-960e-42d63b53981e) — source: FDA, date: September 26, 2025
- [483 - Alcami Carolinas Corporation - 2025-09-26](https://www.keypedia.com/records/483/alcami-carolinas-corporation/af8f8c69-e5c1-487b-8db4-c133d8a121ab) — source: FDA, date: September 26, 2025
- [FDA Inspection 1285106 - Alcami Carolinas Corporation - 2025-09-26](https://www.keypedia.com/records/fda_inspections/alcami-carolinas-corporation/e9cb4335-4945-4fab-92fe-9db7fb125b19) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 26, 2025
- [FDA Inspection 1285106 - Alcami Carolinas Corporation - 2025-09-26](https://www.keypedia.com/records/fda_inspections/alcami-carolinas-corporation/065c4f62-c4dd-4d90-962f-bf8982f02cb5) — source: FDA, date: September 26, 2025
- [FDA Inspection 1285106 - Alcami Carolinas Corporation - 2025-09-26](https://www.keypedia.com/records/fda_inspections/alcami-carolinas-corporation/7505667c-9065-44d7-a830-001c22536988) — classification: No Action Indicated (NAI), source: FDA, date: September 26, 2025
- [FDA Inspection 1285106 - Alcami Carolinas Corporation - 2025-09-26](https://www.keypedia.com/records/fda_inspections/alcami-carolinas-corporation/4b3a1f25-c377-4383-82b7-31b8313004c2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 26, 2025
- [FDA Inspection 1285106 - Alcami Carolinas Corporation - 2025-09-26](https://www.keypedia.com/records/fda_inspections/alcami-carolinas-corporation/17494e30-98d8-4b97-be91-bcb6bf010146) — classification: No Action Indicated (NAI), source: FDA, date: September 26, 2025
- [483 - Alcami Carolinas Corporation - 2025-01-31](https://www.keypedia.com/records/483/alcami-carolinas-corporation/e683890b-16bd-4ca3-a3b4-d412f96052a2) — source: FDA, date: January 31, 2025
- [FDA Inspection 1259644 - Alcami Carolinas Corporation - 2025-01-31](https://www.keypedia.com/records/fda_inspections/alcami-carolinas-corporation/f378f557-dad6-4318-a237-0289286b903c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 31, 2025
- [FDA Inspection 1259644 - Alcami Carolinas Corporation - 2025-01-31](https://www.keypedia.com/records/fda_inspections/alcami-carolinas-corporation/5e52a43f-9b6e-4476-8dd8-0f15c73661e5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 31, 2025
- [FDA Inspection 1259644 - Alcami Carolinas Corporation - 2025-01-31](https://www.keypedia.com/records/fda_inspections/alcami-carolinas-corporation/8f08dff9-6efb-4b9b-b394-c9178e2146cb) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 31, 2025
- [EIR - Alcami Carolinas Corporation - 2021-02-18](https://www.keypedia.com/records/eir/alcami-carolinas-corporation/2d25147a-5022-4dd5-b2cb-0da98026b619) — source: FDA, date: February 18, 2021
- [FDA Inspection 1137604 - Alcami Carolinas Corporation - 2021-02-18](https://www.keypedia.com/records/fda_inspections/alcami-carolinas-corporation/c1eeb433-21eb-43b7-8789-d09114e054cc) — classification: No Action Indicated (NAI), source: FDA, date: February 18, 2021
- [EIR - Alcami Carolinas Corporation - 2019-08-09](https://www.keypedia.com/records/eir/alcami-carolinas-corporation/d338765c-11d7-4922-839c-bd1659fbe06b) — source: FDA, date: August 9, 2019
- [FDA Inspection 1101779 - Alcami Carolinas Corporation - 2019-08-09](https://www.keypedia.com/records/fda_inspections/alcami-carolinas-corporation/4f7a0222-529f-4e15-ba7c-9fd32a952bcc) — classification: No Action Indicated (NAI), source: FDA, date: August 9, 2019
- [EIR - Alcami Carolinas Corporation - 2019-01-29](https://www.keypedia.com/records/eir/alcami-carolinas-corporation/a3003494-5d87-47c0-9dc1-be116b98165d) — source: FDA, date: January 29, 2019

## Related Companies

- [Goodier Cosmetics LLC](https://www.keypedia.com/companies/goodier-cosmetics-llc/5ea9ed0d-142b-4424-a1d6-be8bb095382d)
- [Omega & Delta Co., Inc.](https://www.keypedia.com/companies/omega-delta-co-inc/720ba082-e2a5-4c3a-9c01-b13706d185d0)
- [Consumer Product Partners, LLC](https://www.keypedia.com/companies/consumer-product-partners-llc/3e6f79f9-3572-4485-a899-9a628a8d6aa4)
- [ChemRite CoPac, Inc.](https://www.keypedia.com/companies/chemrite-copac-inc/a81a399e-073f-4c5d-a41f-19bc9d0c0bc3)
- [Syntho Pharmaceuticals, Inc.](https://www.keypedia.com/companies/syntho-pharmaceuticals-inc/911b39ba-d7b3-4ac6-8d51-70ea7dd68454)
- [Swiss American CDMO, LLC](https://www.keypedia.com/companies/swiss-american-cdmo-llc/a4a811fc-a442-480b-a003-b66ee374d059)
- [Nomax Inc](https://www.keypedia.com/companies/nomax-inc/269d696c-bdf9-48a2-9ce3-2ba71aef35aa)
- [Tarmac Products, Inc.](https://www.keypedia.com/companies/tarmac-products-inc/faf7213b-98c9-4af3-8a6a-81115857e208)
- [Church & Dwight Co., Inc.](https://www.keypedia.com/companies/church-dwight-co-inc/d49e7802-d435-46ac-a95b-029bb35bff98)
- [American Regent Inc.](https://www.keypedia.com/companies/american-regent-inc/36234cc5-6f5f-4a82-8c32-5aa05715b722)

## Related Officers

- [company_representative](https://www.keypedia.com/people/mark-lewis/0661f69a-1d28-4faa-a7c3-bce9f05fdcdb)
- [company_representative](https://www.keypedia.com/people/scott-jedrey/5784e5cc-5146-4b16-a756-b281d630a309)
- [company_representative](https://www.keypedia.com/people/gwendalynn-ritchie/6b33781e-62e8-4441-bcd6-19e882cb97fb)
- [company_representative](https://www.keypedia.com/people/joseph-payne/7c5853e8-0ba7-425a-99e2-66235cb15570)
- [recipient](https://www.keypedia.com/people/kenneth-a-domagalski/028372e6-473d-4e21-8d67-82545c4452fc)
- [company_representative](https://www.keypedia.com/people/jacquelyn-uribe/06f6a580-a447-4f25-895c-a5b89270ae53)